USA2 SPOTLIGHT

November 3, 2016 Press Release: Former U.S. Surgeon General Dr. David Satcher was officially announced as a new member of the UsAgainstAlzheimer’s (UsA2) Board of Directors, where he will add his voice and influence to a movement calling for urgency and action to defeat a disease that is the third leading cause of death In the United States.

Please join us at 1pm ET on November 15th for an important 1-hour webinar session for all 43 Advisory Council Member Organizations of the AD-PCPRN, as well as PCORI representatives. We will be discussing our new Clinical Trial Recruitment Tools, launched at Connected Partners Conference in Boston on October 20th. To register, please click here. 

MUST READS

A November 3, 2016 UpperMichigansSource.com article reported that “U.S. Senator Debbie Stabenow (D-MI) announced Thursday that for the first time Medicare will pay for new individual care plans to support Alzheimer’s patients and their families.”

A November 4, 2016 Nature World News article reported that “A team from Merck Research Laboratories has reported the results of early human and animal trials of a drug called verubecestat.” According to the article, “The team is hopeful it could one day be a therapeutic treatment for the  neurocognitive disorder.”

A November 3, 2016 NewsMax.com article reported that “Researchers have new evidence that inflammation plays a key role in concussions, and what they've uncovered will undoubtedly transform the way the medical profession deals with head trauma.”